Literature DB >> 30026623

Successful management of proteinuria and systemic hypertension in a dog with renal cell carcinoma with surgery, telmisartan, and amlodipine.

Yong-Jin Kwon1, Guk-Hyun Suh1, Seong-Soo Kang1, Ha-Jung Kim1.   

Abstract

An 11-year-old neutered male Yorkshire terrier dog was presented with a 3-week history of hematuria and anorexia. A unilateral renal mass was detected and surgically removed. The renal mass was diagnosed on histopathologic examination as a renal carcinoma. Supportive medical therapy was carried out and persistent systemic hypertension was managed using telmisartan.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30026623      PMCID： PMC6005071     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  21 in total

1.  Angiotensin blockade in late autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Kaleab Z Abebe; Arlene B Chapman; Robert W Schrier; William E Braun; Theodore I Steinman; Franz T Winklhofer; Godela Brosnahan; Peter G Czarnecki; Marie C Hogan; Dana C Miskulin; Frederic F Rahbari-Oskoui; Jared J Grantham; Peter C Harris; Michael F Flessner; Charity G Moore; Ronald D Perrone
Journal:  N Engl J Med       Date:  2014-11-15       Impact factor: 91.245

2.  Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats.

Authors:  S Brown; C Atkins; R Bagley; A Carr; L Cowgill; M Davidson; B Egner; J Elliott; R Henik; M Labato; M Littman; D Polzin; L Ross; P Snyder; R Stepien
Journal:  J Vet Intern Med       Date:  2007 May-Jun       Impact factor: 3.333

3.  Canine renal carcinoma with extensive bone metastasis.

Authors:  C Arai; M Ono; Y Une; K Shirota; T Watanabe; Y Nomura
Journal:  J Vet Med Sci       Date:  1991-06       Impact factor: 1.267

4.  Telmisartan as a peroxisome proliferator-activated receptor-γ ligand is a new target in the treatment of human renal cell carcinoma.

Authors:  Kiyoaki Funao; Masahide Matsuyama; Yutaka Kawahito; Hajime Sano; Jamel Chargui; Jean-Louis Touraine; Tatsuya Nakatani; Rikio Yoshimura
Journal:  Mol Med Rep       Date:  2009 Mar-Apr       Impact factor: 2.952

Review 5.  The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications.

Authors:  Karim Touijer; Didier Jacqmin; Louis R Kavoussi; Francesco Montorsi; Jean Jacques Patard; Craig G Rogers; Paul Russo; Robert G Uzzo; Hendrik Van Poppel
Journal:  Eur Urol       Date:  2009-10-20       Impact factor: 20.096

6.  A randomized controlled clinical trial of the use of benazepril and heparin for the treatment of chronic kidney disease in dogs.

Authors:  Jörg Tenhündfeld; Patrick Wefstaedt; Ingo J A Nolte
Journal:  J Am Vet Med Assoc       Date:  2009-04-15       Impact factor: 1.936

7.  Prognostic significance of histologic features in canine renal cell carcinomas: 70 nephrectomies.

Authors:  E F Edmondson; A M Hess; B E Powers
Journal:  Vet Pathol       Date:  2014-05-14       Impact factor: 2.221

8.  Telmisartan treatment of refractory proteinuria in a dog.

Authors:  A C Bugbee; A E Coleman; A Wang; A D Woolcock; S A Brown
Journal:  J Vet Intern Med       Date:  2014-09-30       Impact factor: 3.333

9.  Telmisartan exerts anti-tumor effects by activating peroxisome proliferator-activated receptor-γ in human lung adenocarcinoma A549 cells.

Authors:  Juan Li; Lin Chen; Ping Yu; Bin Liu; Jiang Zhu; Ye Yang
Journal:  Molecules       Date:  2014-03-05       Impact factor: 4.411

10.  Telmisartan induces growth inhibition, DNA double-strand breaks and apoptosis in human endometrial cancer cells.

Authors:  Naoko Koyama; Yoshihiro Nishida; Terukazu Ishii; Toshie Yoshida; Yuichi Furukawa; Hisashi Narahara
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.